期刊文献+

临床调脂治疗的阶梯和综合策略 被引量:11

A stepped and synthetic strategy for clinical lipid-lowering therapy
下载PDF
导出
摘要 通过复习来自PubMed(www.ncbi.nlm.nih.gov)调脂治疗的主要文献,分类调脂治疗的措施并阐述其特点,我们总结了临床调脂治疗的一种新策略,它由缓降型方案(slow-lowering program,S方案)和速降型方案(rapid-lowering program,R方案)组成,包括生活方式干预、中医药、化学药如他汀类、血液处理如献血和其他等措施,适合不同人群调脂治疗的应用。 AIM: To introduce a stepped and synthetic strategy (SSS) for lipid-lowering therapy in clinical. METHODS: The measurement of lipid-lowering treatment was classified and its characteristics was sum marized through retrieval the literatures from PubMed (www.ncbi.nlm.nih.gov) . RESULTS: A novel strategy for clinical lipid-lowering therapy was developed. It consists of slow-lowering program (S Program) and rapid-lowering program (R Program), including lifestyle intervention (LSI), Traditional Chinese Medicine (TCM) , Western medicine, blood management, and so on. CONCLUSION: The SSS is suit to the application of lipidlowering treatment in different population.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2006年第8期625-628,共4页 Chinese Journal of New Drugs and Clinical Remedies
基金 江西省卫生厅基金课题(053196)
关键词 高脂血症 降血脂药 临床方案 调脂治疗 策略 hyperlipidemia antilipemic agents clinical protocols lipid-lowering therapy strategy
  • 相关文献

参考文献34

  • 1The Scandinavian Simvaststin Survivai Study Group, Randomised trial of cholesterol lowering in 4 444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)[J].Lancet, 1994, 344(8934) : 1383-1389.
  • 2The Long-Term Intervention With Pavastatin in Ischaemic Disease (LIPID)Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels[J]. N Engl J Med, 1998, 339(19) : 1349-1357.
  • 3BRIEL M, STUDER M, GLASS TR, et al. Effects of statins on stroke prevention in patients with and without coronary heart disease :a meta-analysis of randomized controlled trials[J]. Am J Med, 2004, 117(8):596-606.
  • 4STRANDBERG TE, PYORALA K, COOK TJ, et al. 4S Group.Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study(4S)[J]. Lancet, 2004,364(9436) :771-777.
  • 5寇文镕.我国血脂异常治疗现状的调查[J].中华心血管病杂志,2001,29(1):15-17. 被引量:145
  • 6徐成斌.血脂异常的药物治疗新进展[J].中华心血管病杂志,2001,29(3):189-192. 被引量:84
  • 7GRUNDY SM, CLEEMAN JI, MERZ CN, et al. National Heart, Lung, and Blood Institute; American College of Cardiology Foundation ; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel Ⅲ guidelines[J]. Circulation, 2004, 110(2) :227-239.
  • 8OKADA K, MAEDA N, TATSUKAWA M, et al. The influence of lifestyle modification on carotid artery intima-media thickness in a suburban Japanese population[J]. Atherosclerosis, 2004,173(2) :329-337.
  • 9胡春松 胡大一.健康的“种子”法则[J].太平洋论坛杂志,2005,1(6):76-76.
  • 10CHENG C, GRAZIANI C, DIAMOND JJ. Cholesterol-lowering effect of the food for heart nutrition education program[J]. J Am Diet Assoc, 2004, 104(12) : 1868-1872.

二级参考文献9

  • 1沈志卫,中华医学杂志,1996年,76卷,156页
  • 2王俊显,中国实验方剂学杂志,1995年,1卷,1页
  • 3李长龄,中国药理学会通讯,1995年,12卷,12页
  • 4朱燕,中国药学杂志,1995年,30卷,656页
  • 5Shepherd J,New Engl J Med,1995年,333卷,1301页
  • 6血脂异常防治对策专题组,中华心血管病杂志,1991年,25卷,169页
  • 7FERDINAND KC. The importance of aggressive lipid management in patients at risk:evidence from recent clinical trials [ J ]. Clin Cardiol, 2004,27(6 Suppl 3) :12 - 15.
  • 8GRAHAM DJ, STAFFA JA, SHATIN D, et al. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs [J]. JAMA,2004,292(21 ) ..2585 -2590.
  • 9方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067

共引文献275

同被引文献45

引证文献11

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部